QF-036, a new HIV maturation inhibitor, shows no toxicity in single or repeated dose studies in rats July 27, 2020
Dewpoint and Merck & Co. collaborate to develop condensate-based drug candidates against HIV July 14, 2020
FDA approves Rukobia for the treatment of adults with multidrug-resistant HIV-1 infection July 3, 2020
GlaxoSmithKline and collaborators identify NF-kappaB activators/HIV latency-reversing agents June 18, 2020
FDA approves dispersible tablet formulation of dolutegravir for infants and children with HIV June 15, 2020
RSS